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Abstract
Background: Early and accurate diagnosis of late-onset sepsis (LONS) in preterm infants is difficult since presenting
signs are subtle and non-specific. Because neonatal sepsis may be accompanied by glucose intolerance and
glucosuria, we hypothesized that glucosuria may be associated with LONS in preterms, in an early stage. We aim to
evaluate the association of glucosuria and late-onset neonatal sepsis (LONS) in preterm infants, in an attempt to
improve early and accurate diagnosis of LONS.
Methods: We performed a prospective observational cohort study in 316 preterms (<34 weeks). We daily measured
glucosuria and followed patients for occurrence of LONS, defined as clinical and blood culture-proven sepsis
occurring after 72 h. Attending physicians were blinded to glucosuria results. We assessed the diagnostic value of
glucosuria for clinical and blood culture-proven LONS using logistic regression analysis.
Results: Glucosuria was found in 65.8 % of 316 preterm patients, and sepsis was suspected 157 times in 123
patients. LONS was found in 47.1 % of 157 suspected episodes. The presence of glucosuria was associated with
LONS (OR 2.59, 95 % CI 1.24–5.43, p = 0.012) with sensitivity 69.0 % and specificity 53.8 % (Likelihoodratio 1.49). After
adjustment for gestational age, birth weight, and postnatal age, this association weakened and was no longer
significant (adjusted OR 2.16; 95 % CI 0.99–1.85, p = 0.055). An increase in glucosuria 48–24 h before onset of
symptoms was not associated with LONS.
Conclusion: In preterms glucosuria is associated with LONS within 24 h, however this association is too weak to be
of diagnostic value.
Keywords: Premature infant, Infection, Nosocomial sepsis, Signs and symptoms, Diagnosis, Glucose,
Hyperglycaemia
Background
Late-onset neonatal sepsis (LONS), mostly defined as
neonatal sepsis occurring after three days of age, is an
important cause of morbidity and mortality in preterm
infants [1]. Early and correct diagnosis of LONS in pre-
term infants is challenging because presenting signs are
subtle and non-specific [2]. Several screening tools have
been investigated to improve early diagnosis of LONS,
such as a combination of clinical signs [3–6], haemato-
logical biomarkers [5–9], changes in microcirculation
[10], heart rate monitoring [11, 12] and use of central-
peripheral temperature gradient [13].
Disturbed glucose homeostasis is frequently seen in
prematurely neonates. Hyperglycaemia has been found
in 25 to 80 % of premature newborns, depending on
their gestational age and birth weight [14–16]. Because
of inadequate hepatic and diminished pancreatic insulin
secretory responsiveness, the risk of hyperglycaemia in-
creases in stressful episodes, such as sepsis [17, 18]. To-
gether with a lower renal threshold, such glycaemic
instability may produce glucosuria in preterm infants,
even in absence of hyperglycemia [19].
Although it has been recognized that hyperglycaemia
may be an important early sign in neonatal sepsis
[18, 20, 21], monitoring of blood glucose requires repeated
blood sampling, with its disadvantages of discomfort,
stress and the risk of iatrogenic anemia and blood transfu-
sions. To the best of our knowledge, the usefulness of
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non-invasive measurement of glucosuria as an early sign
of neonatal sepsis has not been prospectively investigated.
Therefore, the aim of this study was to evaluate the
diagnostic value of changes in glucosuria in the early
detection of LONS in preterm infants.
Methods
Patients
This study was part of a prospective cohort study inves-
tigating clinical signs and symptoms in preterm infants
with suspected LONS, undertaken from July 2005 until
November 2007, at our level-III neonatal intensive care
unit (NICU) in Zwolle, the Netherlands [6]. Eligible
patients included all patients with a postconceptional
age < 34 weeks, > 72 h after birth who had not been on
antibiotic therapy for the last 24 h. Patients were
followed until a corrected gestational age of 35 weeks or
until discharge to other hospitals before 35 weeks [22].
Glucosuria measurement
We prospectively collected data on glucosuria and the
occurrence of late-onset sepsis on a daily basis. Combur
reagent strips (Combur3Test® Roche) were used to test
urine samples for glucosuria, using a semi-quantitative
scoring system of 0 (no glucosuria), 1+ (urine glucose
level 0.6–5.0 mmol/L), 2+ (3.3–7.7 mmol/L), 3+ (14.8–
19.2 mmol/L) and 4+ (52.8–57.2 mmol/L), according to
the product information. Reagent strips were pressed
into the wetted diaper directly or applied to urine col-
lected by needle and syringe from a piece of gauze in the
diaper. Glucosuria was assessed at least 8 times each day
of admission in each infant until a corrected age of
35 weeks. Measurement of glucosuria was performed by
the attending nurse and were collected only for research
purposes. Treating clinicians were unaware of glucosuria
results.
Definitions
A change in glucosuria was defined as an increase of at
least one category; category 1+ and 2++ were pooled
since we previously showed that these categories cannot
be reliably distinguished, because the glucosuria ranges
in these two categories overlap [22, 23].
An episode of suspected sepsis was defined as a clin-
ical suspicion by the attending neonatologist. At the on-
set of each episode, data on clinical signs were assessed
in a standardised way, i.e. the physician completed a
form with clinical signs on which the suspicion of LONS
was based. In addition, routine laboratory investigations,
including blood cultures, C-reactive protein (CRP) and
full blood count were performed [6]. We only included
the first episode of suspected LONS.
The outcome of each episode was classified in 3 mutu-
ally exclusive categories: blood-culture proven sepsis,
clinical (blood-culture negative) sepsis and rejected sep-
sis. The classification was made by the researchers based
on the course of the episode after the start of antibiotics,
using the following predefined definitions of LONS.
Blood-culture proven sepsis was defined as an episode
with positive non-contaminated blood-culture. A posi-
tive blood-culture with organisms regarded as commen-
sals (predominantly Coagulase-negative Staphylococcus)
was defined as contamination. However a positive blood
culture with skin commensals was defined as proven
sepsis when the same organism was found in at least
two blood cultures and/or signs of catheter-related sep-
sis were present, such as inflammation of the skin at the
site of line insertion. Clinical sepsis was defined as
strong clinical suspicion of sepsis as defined by the at-
tending neonatologist or raised CRP during the first
3 days after the onset of suspected infection (>10 mg/l)
or positive haematological markers (leukopenia ≤ 5 x
109/l, leucocytosis ≥ 25 x 109/l, or left shift of the differ-
ential count), despite a negative blood culture. Rejected
sepsis was defined as an episode with negative blood cul-
ture (plus CRP <10 mg/l and negative haematological
markers) or an episode in which no blood culture was
performed and no antibiotics were started. In all our
analyses and results, LONS was defined as blood-culture
proven and/or clinical sepsis, unless stated otherwise.
Statistical analysis
Associations of the degree of glucosuria with patient
characteristics and LONS were analysed by Chi2.
Association between the presence of glucosuria as well
as an increase in glucosuria and the occurrence of LONS
was analysed in the group of patients with suspected in-
fection using multivariate logistic regression analysis,
adjusting for birth weight, gestational and postnatal age,
and the known risk factors for glucosuria. Furthermore,
to determine whether glucosuria has an added value to
diagnose LONS, a multivariable model was developed in
which the association between LONS and glucosuria
was estimated with and without correction of some
major clinical signs in this study population, as we re-
ported earlier [6], i.e. increased respiratory support,
lengthened capillary refill, grey skin and the presence or
recent removal of a central venous catheter.
Analyses were performed using SPSS version 20.0.
Consent and ethical approval
The study was approved by the local medical ethical
committee of our hospital (METC Isala Zwolle, The
Netherlands: Isalakl075). Written informed consent was
obtained from the parents. We state that we have com-
plied with the World Medical Association Declaration of
Helsinki regarding this study.
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Results
During the 2-years study period, a total of 316 of 360 eli-
gible patients < 34 weeks were included. Reasons for ex-
clusion were: short admission < 1 day (n = 7), antibiotics
during the entire admission (n = 31) or missing measure-
ments of glucosuria (n = 6). A total of 187 episodes of
suspected sepsis occurred in 142 patients. To avoid bias
due to double counting of patients who experienced
more than one episode of suspected sepsis, we only in-
cluded the first episode of suspected sepsis in our ana-
lyses. After excluding 30 of 187 episodes, because of
missing glucosuria measurements, we found 157 epi-
sodes of suspected infection in 123 patients, resulting in
a total inclusion of 123 sepsis episodes. Patient charac-
teristics and their suspected sepsis episodes are pre-
sented in Table 1.
Glucosuria
Glucosuria within the individual patient at any time dur-
ing the study period and in varying degrees, was found
in the majority (208/316, 65.8 %) of patients (+ or ++ in
127/316 (40.2 %), +++ in 56/316 (17.7 %), and ++++ in
25/316 (7.9 %)). Glucosuria was negatively associated
with gestational age (ORper week gestational age 0.64; 95%CI
0.56–0.73, p < 0.001) and birth weight (ORper 100g birth
weight 0.80; 95%CI 0.75–0.85, p < 0.001). Glucosuria was
found in 130 (92.2 %) of 141 patients with gestational
age ≤ 30 weeks, as compared to 64 (57.7 %) in 111
patients with gestational age 31–32 weeks and 14
(21.9 %) in 64 patients with gestational age 33–34
weeks (p = 0.001). Glucosuria was more common in
patients with birth weight < 1200 g (99/109, 90.8 %)
than in those ≥ 1200 g (109/207, 52.7 %, p < 0.001).
Glucosuria was equally common in males and females
(115/181, 63.5 % versus 93/135, 68.8 %; p = 0.321).
Sepsis diagnosis
A diagnosis of LONS was made in 58 (47.2 %) of the
123 suspected sepsis episodes: 21 (17.1 %) clinical sepsis
and 37 (30.1 %) culture-proven sepsis. In the culture
proven sepsis episodes the following microbacteriae were
found: Staphylococcus Epidermidis (21.6 %), Staphylo-
coccus Aureus (10.8 %), other Staphylococcus (37,8 %)
Bacillus Cereus (18.9 %), gram negative strains (5.4 %),
Streptococcus (2.7 %) and Candida (2.7 %).
Association of glucosuria with late onset sepsis
Absence of glucosuria
The 108 patients who never had glucosuria had fewer
suspected sepsis episodes (13.9 %) than the 208 patients
with glucosuria ever (60.1 %, OR 9.34; 95 % CI 5.06–
17.22, p < 0.001). This association remained significant
after correction for gestational age and birth weight (OR
4.19; 95 % CI 2.11–8.32, p < 0.001).
Glucosuria in the period before onset of LONS
Suspected sepsis episodes were commonly preceded by
glucosuria between 48 and 24 h (55.7 %), or in the 24 h
before onset of clinical suspicion (56.9 % of episodes).
Glucosuria 48–24 h before onset was not associated with
confirmed LONS, defined as clinical ánd proven sepsis
(OR 1.06, 95 % CI 0.52–2.15, p 0.883), nor with solely
culture-proven sepsis (OR 0.98, 95 % CI 0.45–2.12, p =
0.951). The presence of glucosuria in the 24 h before
clinical suspicion was positively associated with LONS
(OR 2.59, 95 % CI 1.24–5.43, p = 0.012), but not with
culture-proven sepsis (OR 1.61; 95 % CI 0.72–3.56, p =
0.244, Table 2). After adjustment for gestational age,
birth weight and postnatal age, the association between
Table 1 Characteristics of the study population and suspected
sepsis episodes
Patients with suspected infection
n = 123
Gestational age, weeks+days 29+1 (2+1)
Birthweight, g 1187 (345)
Male sex, n (%) 70 (56.9 %)
Died during admission, n (%) 1 (0.8 %)
Age at onset of suspected
infection, days
12 (7–18)
Follow-up, days 24 (14–35)
Respiratory symptoms
(Increase in) apnea, bradycardia
and/or cyanotic spells
56 (45.5 %)
Increased respiratory supporta 53 (43.1 %)
Circulatory symptoms
Pallor/gray skin 61 (49.6 %)
Capillary refill time > 2 s 49 (39.8 %)
Tachycardia 44 (35.8 %)
General symptoms
Temperature instability 86 (69.9 %)
Lethargy 56 (45.5 %)
Irritability 14 (11.4 %)
Laboratory values
C-Reactive protein (mg/l) 2 (0–10)
Leucocytes (10E9/l) 14.0 (8.9–18.0)
Risk factors
CVC in last 24 h 39 (31.7 %)
Mechanical ventilation 12 (9.8 %)
Mean (standard deviation) for gestational age, birth weight. For age at onset
and follow-up in days median (p25 and p75) are given because of
skewed distribution
Data from patients who experienced more than one episode of suspected
infection are from their first episode. For characteristics of sepsis episodes
numbers (percentage) are given, except for “Laboratory values” where median
(p25-p75) are presented. CVC central venous catheter
aIncreased in respiratory support: intensifying the modus, i.e. low flow, CPAP
or endotracheal ventilation and/or degree of respiratory support)
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the degree of glucosuria in the 24-h before the episode
and confirmed LONS became non-significant (OR 2.16,
95 % CI 0.97–4.84, p = 0.060). Diagnostic value of the
presence of glucosuria in the 24-h period before sus-
pected LONS is presented in Table 3.
Increase in glucosuria in the period before onset of LONS
A change in glucosuria in the 24-h preceding before the
onset of suspected LONS was found in 28 (22.8 %) of
episodes (decrease in 9.7 %, no change in 67.5 %, one
category increase in 20.3 %, 2 categories increase in
2.4 % (Table 2)).
An increase in glucosuria in the 24 h before onset of
symptoms was not associated with confirmed clinical
and culture-proven LONS (OR 2.04, 95 % CI 0.86–4.81)
nor for solely culture-proven sepsis (OR 1.26 95 %-CI
0.71–4.15, p = 0.230). Diagnostic value of the increase in
glucosuria in the 24-h period before suspected LONS is
presented in Table 3.
Comparison of glucosuria with other clinical signs and
symptoms in LONS
Correction with some major clinical signs that were
shown to be the strongest predictors of LONS in this
study population, as we reported earlier [6], weakened
the presence of glucosuria to non-significant (OR 1.6;
95 % CI 0.61–4.00, p 0.356). When fitting all the sign
variables in a multivariable model, using backward logistic
regression analysis, the glucosuria as well as an increase in
glucosuria were left out of the final model, meaning that
glucosuria does not add to the predictive value of the
combination of the other signs and symptoms.
Discussion
Principal findings
This study shows that glucosuria is very common in pre-
term infants, with increasing prevalence with lower gesta-
tional age, lower birth weight, and with the occurrence of
late onset sepsis. Although glucosuria in the 24 h before
clinical suspicion of sepsis is associated with confirmed
LONS, the diagnostic value is only marginal. More-over
glucosuria was not associated with culture proven sepsis.
This is probably due to the fact that glucosuria is merely
associated with gestational age and weight, which are
well-known, and stronger risk factors for the occurrence
of LONS. The measurement of glucosuria doesn’t seem to
be of added value to detecting LONS, when compared to
the stronger clinical signs, such as increased respiratory
support severe respiratory or circulatory symptoms [6].
Because glucosuria was more strongly associated with
confirmed LONS (either clinical sepsis or culture-proven
sepsis) than with solely culture-proven LONS, it appears
that (an increase in) glucosuria can possibly be regarded
as a sign of stress and not as a specific marker of infec-
tious sepsis. This is in accordance with earlier reports of
the association of hyperglycaemia with LONS [14, 15, 18].
Our study confirms earlier observations that preterm
infants have an increased risk of glucosuria and that glu-
cosuria is negatively associated with gestational age and
birth weight [14, 16, 21]. Our study is the first, however, to
assess the value of the presence and degree of glucosuria
as an early marker in detecting LONS in preterm infants.
Strengths and weaknesses
The strength of our study is that the data were prospect-
ively collected in a well-defined population of preterm
Table 2 Association of glucosuria in the 24-h period before clinical suspicion of late-onset neonatal sepsis
n = 123 Prevalence Rejected infection Clinical sepsis Proven sepsis (positive bloodculture)
n = 65 n = 21 n = 37
Maximum glucosuria 24 h before
onset of suspected infection
0 53 (43.1 %) 35 (66.0 %) 5 (9.4 %) 13 (24.5 %)
+/++ 54 (43.9 %) 23 (42.6 %) 12 (22.2 %) 19 (35.2 %)
+++ 12 (9.8 %) 6 (50.0 %) 1 (8.3 %) 5 (41.7 %)
++++ 4 (3.2 %) 1 (25.0 %) 3 (75.0 %) 0 (0 %)
Increase in glucosuria 28 (22.8 %) 11 (39.0 %) 6 (17.1 %) 11 (30.1 %)
Table 3 Diagnostic value of glucosuria 0–24 h before clinical suspicion of LONS in preterm infants
123 episodes of
suspected LONS
Confirmed clinical and culture proven LONS
n = 58 (47.2 %)
prevalence sensitivity specificity ppv npv LR+ LR−
Presence of glucosuria 56.7 % 69.0 % 53.8 % 57.1 % 66.0 % 1.49 0.58
Increase in glucosuria 22.8 % 29.3 % 83.1 % 60.7 % 56.8 % 1.73 0.85
LONS Late-onset neonatal sepsis, ppv positive predictive value, npv negative predictive value, LR Likelihoodratio
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infants suspected of late-onset sepsis. This is important
because both clinical symptoms and inflammatory re-
sponses may differ between preterm and term infants [24].
Attending physicians and researchers who classified the
sepsis episodes were strictly blinded to glucosuria results.
This is crucial to prevent incorporation bias and thus
overestimation of diagnostic accuracy or associations [25].
We consider it to be an additional strength that we
did not only include blood-culture proven sepsis, but
also clinical blood-culture negative sepsis, reflecting
daily practice in neonatal intensive care wards.
An important weakness of our study was the lack of a
strict definition of suspicion of sepsis. We left it up to
the attending physician to decide whether the signs and
symptoms gave rise to clinical suspicion of a LONS,
realizing that this will lead to a certain inter-physician
variation. However, the definition of the outcome - con-
firmed LONS - was clear and decided on by the re-
searchers. Another point of criticism is that we only
analyzed the glucosuria results in suspected episodes of
LONS and thus did not further analyse the predictive
value of glucosuria. This means that we do not know
how often preterms experience a change in degree of
glucosuria without subsequent clinical suspicion of sep-
sis. It would be interesting to know whether monitoring
of daily glucosuria, is of additional value above monitor-
ing of clinical findings and vital parameters, for early
detection of LONS.
Conclusions
In conclusion, we demonstrated that changes in the de-
gree of glucosuria occur early in the course of LONS in
preterm infants, but that this marker is only of marginal
diagnostic value.
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